Succeed in Japan and Australia

More Success in International Business!

With the Export Initiative for the Healthcare Industry, the Federal Government supports German companies in the sector in opening up new export markets. We offer free market information and assist with marketing abroad and networking with international partners.

Our new study about the Japanese Healthcare Market in the field of pharmaceuticals and biopharmaceuticals provides a detailed overview of the market development, opportunities and the regulatory framework.
It also offers insights into Japan's heavily subsidised research landscape and specific recommendations for successful market entry. Despite transparent regulation, cultural differences and specific regulations pose major challenges for small and medium-sized companies from Germany.

From our study about the Australian Healthcare Market in the field of pharmaceuticals and biopharmaceuticals you can expect:

Market development and opportunities

The demand for pharmaceuticals in Australia is increasing due to the ageing society and the high level of prosperity of the population. The government is promoting the expansion of industrial research and the improvement of the healthcare system. Innovative treatment options and the increasing number of chronic diseases are further strengthening the market.

Regulations and challenges

Although patented drugs have a strong market share, the government promotes the use of generics and biosimilars to contain costs. Prices in the public reimbursement system are low and the authorisation processes are complex.

Research and development

Thanks to generous subsidies, research and development as well as clinical trials can be carried out cost-effectively. The free trade agreement with the EU could create additional business opportunities.

* Advertisement - in cooperation with Exportinitiative Gesundheitswirtschaft*

Veröffentlicht: 05.03.2025